The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is the predictive and prognostic impact of sporadic and familial microsatellite instable stage III colon cancer different? A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials.
 
Aziz Zaanan
Consulting or Advisory Role - Amgen; Lilly; Merck Serono; Roche; Sanofi
Research Funding - Amgen
 
Qian Shi
No Relationships to Disclose
 
Julien Taieb
Consulting or Advisory Role - Amgen; Baxalta; Celgene; Lilly; Merck KGaA; MSD; Roche; SERVIER; Sirtex Medical
Speakers' Bureau - Amgen; Baxalta; Lilly; Merck; MSD; Roche/Genentech; Sanofi; SERVIER
 
Steven R Alberts
No Relationships to Disclose
 
Jeffrey P. Meyers
No Relationships to Disclose
 
Thomas C. Smyrk
No Relationships to Disclose
 
Catherine Julié
No Relationships to Disclose
 
Ayman Zawadi
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; BeiGene; Biocartis; Boehringer Ingelheim; Chugai Pharma; Foundation Medicine; Genentech; Genmab; HalioDx; Halozyme; Imugene; Inflection Biosciences; Ipsen; Kura Oncology; Lilly; Menarini; Merck Serono; Merrimack; Merus; Molecular Partners; MSD; Novartis; Peptomyc; Pfizer; Pharmacyclics; ProteoDesign; Rafael Pharmaceuticals; Roche; Roche; Sanofi; Seagen; Seagen; Servier; Symphogen; Taiho Pharmaceutical; VCN Biosciences
 
Enrico Mini
No Relationships to Disclose
 
Richard M. Goldberg
Consulting or Advisory Role - Merck; Merck KGaA; Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Merck; Merck KGaA
 
Gunnar Folprecht
Honoraria - Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck KGaA; Merck Sharp & Dohme; Mundipharma; Roche/Genentech; Sanofi/Aventis; SERVIER
Research Funding - Merck KGaA
 
Jean Luc VAN Laethem
No Relationships to Disclose
 
Karine Le Malicot
No Relationships to Disclose
 
Daniel J. Sargent
Consulting or Advisory Role - Abbvie; Acerta Pharma; ARIAD; Astellas Pharma; AstraZeneca/MedImmune; Biothera; Celldex; Exelixis; Genentech; Incyte; Kyowa Hakko Kirin; Medivation; Merck; Merrimack; Nektar; Novartis; Pharmacyclics; Pique; Spiration; Xbiotech
Research Funding - Celgene (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene
 
Pierre Laurent-Puig
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Merck; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Patents, Royalties, Other Intellectual Property - Inventor of mir31-3p licence to integragen
Travel, Accommodations, Expenses - Merck; Roche
 
Frank A. Sinicrope
Stock and Other Ownership Interests - illumina
Honoraria - American Society of Clinical Oncology; Imedex
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Roche (Inst); Ventana Medical Systems (Inst)
Research Funding - Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - ventana medical systems